谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

62 Pre-clinical evaluation of LYS6KAKT1, a novel, highly selective, orally bioavailable dual inhibitor of p70 S6 Kinase and AKT currently in phase I clinical trials for cancer

Sandaruwan Geeganage,Lillian Sams, Simpson Joseph, Theodore G Shepherd, R Dally,Les H Brail, Tzefang Wang,Andrew R Capen,George M Rodgers,Edward J Perkins

European Journal of Cancer Supplements（2010）

引用 0|浏览8
暂无评分
关键词
phase i clinical trial
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要